EC Approves BMS’ Perioperative Opdivo and Chemo for NSCLC

EC approves BMS’ perioperative Opdivo and chemo for NSCLC

The EC has approved BMS' perioperative regimen of neoadjuvant Opdivo combined with chemotherapy for NSCLC.

Perioperative immunotherapy strategies for resectable non-small cell lung cancer

Perioperative immunotherapy strategies for resectable non-small cell lung cancer This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To compare, via a network meta-analysis, the effectiveness and safety of different immunotherapy agents that are administered in a perioperative setting to people with resectable non small-cell lung cancer To perform indirect comparisons in order to generate a clinically meaningf…